# DESCRIPTION

## BACKGROUND

### Field of Invention

- define field of invention

### Background Information

- describe WNV
- motivate need for vaccine

## SUMMARY

- summarize invention

## DETAILED DESCRIPTION

- define scope of invention
- describe recombinant subunit protein WN-80E
- motivate use of TLR-4 agonist and saponin adjuvants
- describe vaccine formulation and adjuvants
- outline pharmaceutical composition and formulation materials
- describe administration and use of vaccine
- provide examples of vaccine composition and administration

### West Nile Virus Vaccine

- introduce WN-80E antigen and SLA adjuvant
- describe materials and methods for immunogenicity studies
- outline challenge studies and plaque assay procedures
- detail antibody responses and intracellular cytokine staining
- introduce West Nile Virus vaccine
- present graphical representations of data
- describe results of single dose immunization with WN-80E
- discuss protective efficacy of SLA in multiple formulations
- describe results of single immunization with WN-80E and SLA
- discuss induction of germinal center B-cells and pre-plasmablasts
- discuss implications of results for WNV vaccine development
- compare SLA with other adjuvants
- discuss potential for broadened protection against diverse flaviviruses
- summarize results and future directions

### Example 2

- describe WNV vaccine formulation and efficacy

### Clinical Testing of West Nile LSQ Vaccine

- outline clinical trial design and objectives

## CONCLUSIONS

- summarize adjuvant formulation

